GARDEN STAGE LTD-A (GSIW) Fundamental Analysis & Valuation

NASDAQ:GSIW • KYG3730L1234

Current stock price

19.99 USD
+0.47 (+2.41%)
At close:
19.3 USD
-0.69 (-3.45%)
After Hours:

This GSIW fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. GSIW Profitability Analysis

1.1 Basic Checks

  • GSIW had negative earnings in the past year.
  • In the past year GSIW has reported a negative cash flow from operations.
GSIW Yearly Net Income VS EBIT VS OCF VS FCFGSIW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 -2M -4M -6M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -33.36%, GSIW is doing worse than 92.15% of the companies in the same industry.
  • GSIW has a worse Return On Equity (-54.46%) than 85.54% of its industry peers.
Industry RankSector Rank
ROA -33.36%
ROE -54.46%
ROIC N/A
ROA(3y)-18.81%
ROA(5y)N/A
ROE(3y)-41.54%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GSIW Yearly ROA, ROE, ROICGSIW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 -100 -200 -300

1.3 Margins

  • GSIW has a Gross Margin of 65.44%. This is in the better half of the industry: GSIW outperforms 74.79% of its industry peers.
  • GSIW's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for GSIW so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.82%
GM growth 5YN/A
GSIW Yearly Profit, Operating, Gross MarginsGSIW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 -100 -200 -300

8

2. GSIW Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for GSIW remains at a similar level compared to 1 year ago.
  • There is no outstanding debt for GSIW. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GSIW Yearly Shares OutstandingGSIW Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 5M 10M 15M
GSIW Yearly Total Debt VS Total AssetsGSIW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 5M 10M 15M

2.2 Solvency

  • GSIW has an Altman-Z score of 280.62. This indicates that GSIW is financially healthy and has little risk of bankruptcy at the moment.
  • GSIW has a Altman-Z score of 280.62. This is amongst the best in the industry. GSIW outperforms 99.17% of its industry peers.
  • There is no outstanding debt for GSIW. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 280.62
ROIC/WACCN/A
WACCN/A
GSIW Yearly LT Debt VS Equity VS FCFGSIW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 5M -5M

2.3 Liquidity

  • A Current Ratio of 2.51 indicates that GSIW has no problem at all paying its short term obligations.
  • GSIW's Current ratio of 2.51 is fine compared to the rest of the industry. GSIW outperforms 79.75% of its industry peers.
  • GSIW has a Quick Ratio of 2.51. This indicates that GSIW is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of GSIW (2.51) is better than 79.75% of its industry peers.
Industry RankSector Rank
Current Ratio 2.51
Quick Ratio 2.51
GSIW Yearly Current Assets VS Current LiabilitesGSIW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 2M 4M 6M 8M 10M

4

3. GSIW Growth Analysis

3.1 Past

  • GSIW shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.82%, which is quite impressive.
  • The Revenue has grown by 319.70% in the past year. This is a very strong growth!
  • GSIW shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.26% yearly.
EPS 1Y (TTM)28.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.14%
Revenue 1Y (TTM)319.7%
Revenue growth 3Y33.26%
Revenue growth 5YN/A
Sales Q2Q%382.92%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GSIW Yearly Revenue VS EstimatesGSIW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 1M 2M 3M 4M 5M

0

4. GSIW Valuation Analysis

4.1 Price/Earnings Ratio

  • GSIW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GSIW Price Earnings VS Forward Price EarningsGSIW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GSIW Per share dataGSIW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. GSIW Dividend Analysis

5.1 Amount

  • GSIW does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

GSIW Fundamentals: All Metrics, Ratios and Statistics

GARDEN STAGE LTD-A

NASDAQ:GSIW (3/13/2026, 8:00:02 PM)

After market: 19.3 -0.69 (-3.45%)

19.99

+0.47 (+2.41%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)01-20
Earnings (Next)07-29
Inst Owners2.64%
Inst Owner Change21.29%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.03B
Revenue(TTM)8.87M
Net Income(TTM)-10.81M
AnalystsN/A
Price TargetN/A
Short Float %0.13%
Short Ratio0.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 680.22
P/FCF N/A
P/OCF N/A
P/B 303.81
P/tB 304.79
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.03
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -33.36%
ROE -54.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.44%
FCFM N/A
ROA(3y)-18.81%
ROA(5y)N/A
ROE(3y)-41.54%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.82%
GM growth 5YN/A
F-Score5
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.5%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.51
Quick Ratio 2.51
Altman-Z 280.62
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)195.33%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.57%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)319.7%
Revenue growth 3Y33.26%
Revenue growth 5YN/A
Sales Q2Q%382.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-37.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y33.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.79%
OCF growth 3YN/A
OCF growth 5YN/A

GARDEN STAGE LTD-A / GSIW Fundamental Analysis FAQ

What is the fundamental rating for GSIW stock?

ChartMill assigns a fundamental rating of 3 / 10 to GSIW.


What is the valuation status for GSIW stock?

ChartMill assigns a valuation rating of 0 / 10 to GARDEN STAGE LTD-A (GSIW). This can be considered as Overvalued.


How profitable is GARDEN STAGE LTD-A (GSIW) stock?

GARDEN STAGE LTD-A (GSIW) has a profitability rating of 1 / 10.


How financially healthy is GARDEN STAGE LTD-A?

The financial health rating of GARDEN STAGE LTD-A (GSIW) is 8 / 10.